Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

@article{Li2019ActivatingCP,
  title={Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy},
  author={Anping Li and Ming Yi and Shuang Qin and Yongping Song and Q. Chu and Kongming Wu},
  journal={Journal of Hematology \& Oncology},
  year={2019},
  volume={12}
}
During tumor progression, a subset of cancer cells escape from immune surveillance and eventually develop into measurable tumor mass. Cancer immunotherapy eradicates tumor cells by enhancing multiple steps in cancer-immunity cycle including antigen presentation, T cell priming, activation, and immune killing activity. Immunotherapy has been verified as an effective strategy in multiple cancers, but some problems still exist in actual clinical practice such as frequent primary and adaptive… Expand
cGAS-STING, an important pathway in cancer immunotherapy
cGAS-STING signaling in cancer immunity and immunotherapy.
Prospects for combining immune checkpoint blockade with PARP inhibition
Cancer immunotherapy with γδ T cells: many paths ahead of us
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 118 REFERENCES
The host STING pathway at the interface of cancer and immunity.
A STING-Activating Nanovaccine for Cancer Immunotherapy
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
...
1
2
3
4
5
...